Compass Therapeutics

This is the first human study of an experimental drug called CTX-10726 for patients with advanced cancers that have stopped responding to standard treatments. The trial will test increasing doses of the drug to find the safest amount and see how the body processes it. Researchers…

This is the first study in people testing a new drug called CTX-8371 for several advanced cancers that have stopped responding to standard treatments. Researchers will give increasing doses to a small group of patients to check if the drug is safe and what side effects it causes.…